Friday, October 10, 2014

07:00 AM Breakfast and Exhibits
SESSION 4
Risk & Prevention
Session Chair: Virginia Kaklamani, MD, DSc
08:15 AM What’s New with BRCA mutations?
Claudine Isaacs, MD
08:45 AM Take Home Messages from the Women's Health Initiative
Rowan Chleblowski, MD, PhD
09:15 AM Update on LCIS: Pathogenesis and Management
Tari King, MD
09:45 AM Break
10:15 AM Breast Cancer Risk Assessment: State of the Art
Carol Fabian, MD
10:45 AM DCIS: Can We Tailor Management?
Beryl McCormick, MD
11:15 AM Questions and Answers
11:30 AM CONNIE MOSKOW MEMORIAL DEBATE
All Women with Triple Negative Breast Cancer Should Receive Neoadjuvant Therapy
Pro: Eric Winer, MD; Con: Anthony Elias, MD
12:30 PM Lunch Break and Dessert with Exhibitors
SESSION 5
Endocrine Therapy
Session Chair: V.Craig Jordan, OBE, PhD, DSc
01:45 PM Overcoming Endocrine Resistance in the Clinic
Ruth O’Regan, MD
02:15 PM Compliance: Unseen Foe in Breast Cancer Management
Dawn Hershman, MD
02:45 PM SERMS Revisited: New SERMS your Patients are Taking
V. Craig Jordan, OBE, PhD, DSc
03:15 PM Break
03:45 PM Using Genomic Profiles to Individualize Local Therapy
Eleftherios Mamounas, MD, MPH
04:15 PM Is Hypofractionated RT the New Standard?
Jay Harris, MD
04:45 PM Questions and Answers
05:00 PM Adjourn



© Robert H. Lurie Comprehensive Cancer Center of Northwestern University